Quantinuum (NASDAQ:QNT) Coverage Initiated at Rosenblatt Securities

Investment analysts at Rosenblatt Securities started coverage on shares of Quantinuum (NASDAQ:QNT) in a note issued to investors on Monday,Benzinga reports. The brokerage set a “buy” rating on the stock.

Several other equities research analysts have also recently commented on QNT. Evercore initiated coverage on Quantinuum in a research note on Monday. They set an “outperform” rating for the company. Wall Street Zen raised Quantinuum to a “hold” rating in a research note on Saturday, June 20th. TD Cowen initiated coverage on Quantinuum in a report on Monday. They set a “buy” rating on the stock. Cantor Fitzgerald began coverage on shares of Quantinuum in a research report on Monday. They set an “overweight” rating for the company. Finally, Bank of America assumed coverage on shares of Quantinuum in a research note on Monday. They issued a “buy” rating and a $100.00 price objective for the company. Nine analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $91.60.

Quantinuum Stock Performance

QNT stock opened at $75.57 on Monday. Quantinuum has a 1-year low of $50.10 and a 1-year high of $81.48.

Insider Buying and Selling at Quantinuum

In related news, insider Kevin Scott Dehoff acquired 15,000 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, with a total value of $900,000.00. Following the acquisition, the insider owned 126,460 shares of the company’s stock, valued at approximately $7,587,600. This trade represents a 13.46% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Joseph Jimenez acquired 66,665 shares of the stock in a transaction dated Friday, June 5th. The stock was bought at an average cost of $60.00 per share, with a total value of $3,999,900.00. Following the completion of the purchase, the director owned 72,498 shares of the company’s stock, valued at approximately $4,349,880. The trade was a 1,142.89% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders have acquired 411,032 shares of company stock worth $24,661,920.

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.